Drawing on Novogene’s global genomics and multi-omics capabilities, our regional teams provide local scientific expertise and support across Asia-Pacific, the Middle East and Africa. Our teams are based in Singapore, Australia, Hong Kong, Japan, South Korea, India and Dubai.
8,000+
Organisations Served
3 Million+
Samples Processed Annually
40,000+
SCI Publications
Falcon streamlines sample‑to‑data workflows with traceable, standardized processes – delivering reproducibility, speed, and flexibility for rapid discovery.

Access advanced technologies across genomics, single-cell, spatial omics, proteomics and metabolomics research areas.

Analyze complex multi-omics datasets with high-performance computing and flexible bioinformatics support.

This landmark project will leverage Thermo Fisher Scientific's Orbitrap Astral™ platform, Seer's Proteograph® Product Suite, and the Olink® Reveal Assay to analyze 10,000 plasma samples, advancing biomarker discovery and precision medicine research.
For more information, please visit Phase II: PRECISE SG100K.


Explore transcriptome-wide gene expression.
Profile transcriptomes at single-cell resolution.
Profile metabolites to reveal biological pathways.
Investigate protein biomarkers and pathways.

Have a project in mind?
Send us your enquiry and a Novogene Specialist will be in touch.
Drawing on Novogene’s global genomics and multi-omics capabilities, our regional teams provide local scientific expertise and support across Asia-Pacific, the Middle East and Africa. Our teams are based in Singapore, Australia, Hong Kong, Japan, South Korea, India and Dubai.
8,000+
Organisations Served
3 Million+
Samples Processed Annually
40,000+
SCI Publications
Falcon streamlines sample‑to‑data workflows with traceable, standardized processes – delivering reproducibility, speed, and flexibility for rapid discovery.

Access advanced technologies across genomics, single-cell, spatial omics, proteomics and metabolomics research areas.

Analyze complex multi-omics datasets with high-performance computing and flexible bioinformatics support.

This landmark project will leverage Thermo Fisher Scientific's Orbitrap Astral™ platform, Seer's Proteograph® Product Suite, and the Olink® Reveal Assay to analyze 10,000 plasma samples, advancing biomarker discovery and precision medicine research.
For more information, please visit Phase II: PRECISE SG100K.


Explore transcriptome-wide gene expression.
Profile transcriptomes at single-cell resolution.
Profile metabolites to reveal biological pathways.
Investigate protein biomarkers and pathways.

Have a project in mind?
Send us your enquiry and a Novogene Specialist will be in touch.